Platelet Concentration Systems Market

Platelet concentration systems are pivotal medical devices that are used for concentrating platelets collected from donor's blood. The platelet-rich plasma or PRP derived from these systems contain a higher density of platelets than normal blood. PRP is defined as plasma with an elevated platelet concentration over that of normal plasma and can be created using centrifugation or gravity filtration of autologous blood. PRP is being extensively used in various regenerative medicine applications such as orthopedic surgeries for treating muscle, bone and joint injuries. The systems are equipped with advanced technologies that precisely separate platelets from other blood components through centrifugation followed by their careful compression into a concentrated formulation. They deliver safe and clinically effective volumes of autologous PRP which boost the body's natural healing abilities. With the aging global population and rise in sports injuries, the demand for less invasive platelet concentration techniques is augmenting.  

Market Dynamics:

The global platelet concentration systems market is driven by the rising incidence of chronic diseases, sports injuries, and trauma cases that considerably benefit from PRP therapies. The growing adoption of tissue engineering approaches in reconstructive procedures and an increasing dependence on blood-derived products for wound care are fueling the market growth. However, high costs associated with these devices and lack of reimbursement policies for PRP-based treatments in some regions can impede widespread adoption. Moreover, each system requiring regulatory clearances poses challenges for market players. The untapped opportunities lie in developing economies with large geriatric populations and in utilizing platelet concentrate for new medical applications. Ongoing R&D for improving concentration accuracy, automating the process and expanding indications are expected to create lucrative prospects over the forecast period.

Key Features of the Study:

• This report provides an in-depth analysis of the global platelet concentration systems market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global platelet concentration systems market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Anthrax Inc., Stryker Corporation, Johnson & Johnson’s, Zimmer Biomet Holdings Inc., Terumo Corporation, Arteriocyte Medical Systems, Inc., Exactech Inc., Harvest Technologies Corp., and Nuo Therapeutics, Inc., Haemonetics Corporation, Fresenius SE & Co. KGaA, Macopharma, BioIVT, Stago, and Pall Corporation
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global platelet concentration systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global platelet concentration systems market

Platelet Concentration Systems Market Detailed Segmentation:

• By Technology
  • Apheresis Technology
  • Single Spin Technology
  • Double Spin Technology  
• By Application
  • Orthopedics
  • Cosmetic Surgery and Dermatology
  • Neurology
  • Cardiology
  • Others (Ophthalmology and Others)
• By End User
  • Hospital
  • Blood Banks and Transfusion Centers
  • Ambulatory Surgical Centers
  • Others (Research Laboratories, Stand-alone Processing Facilities)
• By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Top Companies in the Global Platelet Concentration Systems Market
  • Anthrax Inc.
  • Stryker Corporation
  • Johnson & Johnson’s
  •  Zimmer Biomet Holdings Inc.
  • Terumo Corporation
  • Arteriocyte Medical Systems, Inc.
  • Exactech Inc.
  • Harvest Technologies Corp.
  • Nuo Therapeutics, Inc.
  • Haemonetics Corporation
  • Fresenius SE & Co. KGaA
  • Macopharma
  • BioIVT
  • Stago
  • Pall Corporation